ArticleInterventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences2025
CELT vascular closure device for larger NES arteriotomies: A single-center retrospective analysis.
Article in Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Early experience with CELT ACD vascular access closure device for neurointerventional procedures.The journal of vascular access · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction/PurposeThe shift from transfemoral to transradial access in interventional cardiology has gained momentum due to fewer access site complications, earlier ambulation, and improved patient comfort. Adoption in neuroendovascular procedures has been slower due to anatomical challenges, a steeper learning curve, and reliance on transfemoral devices. Shapiro et al. reported a 4.6% total and 1.6% major complication rate with transfemoral mechanical thrombectomy (MT). While transradial MT aims to reduce such risks, small radial arteries pose concerns such as vasospasm and catheter entrapment. For large-bore access sites (>8F), available percutaneous closure options are limited. Vascular closure devices offer immediate hemostasis-even in anticoagulated patients-but data are limited on off-label use in oversized arteriotomies. We present a single-center retrospective experience using a 7F CELT closure device on 9F arteriotomies in MT.Materials/MethodsWe retrospectively reviewed patients from January 2021 to 2023 who underwent endovascular procedures using 9F femoral sheaths closed with a 7F CELT device. Data included demographics, procedural details, antithrombotic use, hemostasis efficacy, and closure-related complications.ResultsMost patients (96.3%) underwent MT. The CELT device achieved hemostasis in line with the primary outcome definition in 93.2% (95% CI [90.3, 96.0]). Major complications included two cases (0.5%) of lower limb ischemia requiring surgical repair. No retroperitoneal hematomas or transfusions occurred.ConclusionThe 7F CELT closure device demonstrated a 93.2% efficacy rate and a 95% complication-free rate when used off-label for 9F arteriotomies, supporting its potential viability in high-acuity neuroendovascular procedures.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.